Overall, our study aimed for an improved understanding of an inhibitory crosstalk between FOXA2 and HNF6 in metastasizing colon cancer and to utilize this knowledge for the development of an siRNA mediated therapeutic approach. The gene discussed is FOXA2; the disease is malignant colon neoplasm.